Skip to main content
C. Kent Osborne, MD, Oncology, Houston, TX

C. Kent Osborne MD

Oncology•Houston, TX

Breast Cancer, Hematologic Oncology

Director, Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine

Join to view full profile

  • 1919 Old Spanish Trl FL 8Houston, TX 77054

  • Phone+1 832-957-6500

  • Fax+1 713-798-1990

Dr. Osborne is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Osborne's full profileAlready have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1974 - 1977
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1972 - 1974
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 1972

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1977 - 2027
  • MD State Medical License
    MD State Medical License 1974 - 1991
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
  • America's Top Doctors Castle Connolly, 2002-2014

Publications & Presentations

PubMed

Journal Articles

  • The Oral Selective Oestrogen Receptor Degrader (SERD) AZD9496 Is Comparable to Fulvestrant in Antagonising ER and Circumventing Endocrine Resistance  
    Rinath Jeselsohn, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff, Nature

Press Mentions

  • Dr. Nancy Davidson Receives the 2026 David Karnofsky Award for Advancing Breast Cancer Research and Care
    Dr. Nancy Davidson Receives the 2026 David Karnofsky Award for Advancing Breast Cancer Research and CareApril 30th, 2026
  • Postmenopausal Women Who Shed Pounds See Lower Breast Cancer Risk
    Postmenopausal Women Who Shed Pounds See Lower Breast Cancer RiskDecember 18th, 2017
  • Fulvestrant Bests Anastrozole in Advanced Breast Cancer
    Fulvestrant Bests Anastrozole in Advanced Breast CancerDecember 18th, 2014

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. C. Kent Osborne, Dr. C. Kent Osborne, MD, Dr. C Osborne